skip to Main Content
(919) 657-0660

We’ll take you from lab-scale to clinical‑scale to commercial.

Whether you have a small molecule, a peptide, or a protein, and whether you need an injectable, topical, or controlled release oral solutions, we have the experts to help you – in the U.S., Europe, or anywhere.

Drug Substance

  • Small molecule
  • Peptides/protein
  • Oligonucleotides
  • Whole cell

Dosage forms

  • Solid dosage – IR, SR, CR
  • Solutions, suspensions, emulsions
  • Creams, lotions, ointments
  • Drug/device combination products

Routes

  • Oral
  • Parenteral
  • Topical (dermal, ophthalmic, intravaginal, etc.)
  • Inhalation (pulmonary and nasal)

Some Specialties

  • Solubility enhancement
  • Stability improvement
  • Bioavailability enhancement
  • Modified PK profiles

Our experts will help source and secure the right vendors, generate the ideal synthetic scheme, and develop all the necessary analytical methods to move your development project forward.

Proteins, peptides, and nucleotides each present unique challenges in generation, purification, and analysis. While a single chromatographic test can tell you how potent and pure a small molecule is, a whole palette of analyses is needed to control for everything that can go wrong with a 100 kDal protein.

Our large molecule experts have the knowledge and experience to shepherd your API from petri dish to commercial-scale fermentation. Beyond proteins, we have helped clients develop peptide and protein conjugates, oligonucleotides, genes, and even whole-cell therapeutics.

Our team of CMC experts are highly experienced in meeting requirements for each stage of development and in preparing CMC sections of regulatory applications.

Managing quality is a top priority.

At PharmaDirections, we engage Quality specialists to perform the duties of a virtual quality assurance unit. One thing that separates us is that we offer the ability to generate a limited quality system to fit the needs of a virtual sponsor.

Here’s how it works: Vendors take responsibility for the bulk of quality-related work. Yet final responsibility for the drug product remains in the hands of the sponsor even if all work is outsourced. Typically, a small number of SOPs are needed to detail what needs to get done and who needs to do it in order to allow a drug into the clinic.

, PharmaDirections

Drug Developers

We have seasoned experts in many different therapeutic moieties and indications that will strategize and build a full-spectrum team around your innovation to push it forward, into patients and toward approval.

, PharmaDirections

Program Managers

Our Program Leaders and Project Managers drive the execution of coordinated campaigns from drug discovery to preclinical research to clinical trials.

, PharmaDirections

Drug Discoverers

Our experts design and execute a variety of studies aimed at rational lead selection and optimization based on pre-established target product profiles.

, PharmaDirections

CMC Experts & Quality Managers

From sourcing starting materials to formulating your drug product, we provide expertise in chemistry, biology, formulation and manufacturing of both small and large molecules.

, PharmaDirections

Preclinical Experts

We design and oversee the in vivo and in vitro studies you need to assure regulators your molecule is safe enough to treat humans.

, PharmaDirections

Predictive Pharmacokinetic Modelers

We analyze PK data and use sophisticated computer tools to design dosage forms and optimize dosing regimens.

, PharmaDirections

Regulatory Experts & Managers

Our seasoned experts have helped advance countless new and repurposed drugs from investigational applications (e.g. INDs) through to marketing approval in the U.S. and abroad.

, PharmaDirections

Intellectual Property Inventors

Patent applications are part of regular routine. We generate your IP but we take no ownership stake in it.

, PharmaDirections

REQUEST A CONSULTATION

Contact Cathi Clark, our VP of Business Development to Get Started!

Back To Top